Adding Draganfly (DFLYF) $1.40 to Watch List.
Amnnounces Deal to Supply 3,000 Drones to Steve Wozniak via 'Woz EDU" Partnership.
SekurMessenger vs. the WhatsApp Messenger.
Can the World’s Most Secure Text Messenger and Email Provider Challenge the Industry Leader WhatsApp?
Can A Tiny...
20 Minutes with Sekur (SWISF) CEO and Internet Security Expert Alain Ghiai.
Alain Ghiai, founded the Company and has served as Director and CEO since March 2017. He has served as President and Corporate...
Another Look at the Snowflake (SNOW) Mega IPO.
We haven't looked at Snowflake (SNOW) since its amazing IPO debut. It was priced at $120 and opened for trading at $245...
Clever and Sophisticated Bing Chat AI Malware Ads.
Imagine asking Bing Chat a question..
"Hello Bing, I would like to download advanced IP scanner"
Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
Adding OmniQ (OMQS) $5.00 to the Watch List.
Artificial Intelligence (AI) Fans Take a Peek.
This is our Latest Attempt at...
A New Stock Exchange for Israeli Tech Companies, Backed by NYSE.
With Toronto Grabbing Some of the Best Israeli Tech Listings Away From NASDAQ, We Saw This Coming.
From...
Draganfly (DFLYF) Holds ‘Pole Position’ in Race for Drone Supremacy After Chinese Barred from...
STREETWISE REPORTS - March 3, 2020
The company establishes a toehold with U.S....
OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share.
Without disrupting legacy sales - CEO Shai...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
